[
  {
    "id": "006aa4a0d68d04820c8f5d32b42eb880",
    "title": "Complete Response Letter, Warning Letter and Shareholder Lawsuit Follow FDA Data Integrity Findings - JD Supra",
    "link": "https://news.google.com/rss/articles/CBMiigFBVV95cUxQUGhhVWRtUDA3TEtVa0p6VElTMGE1eXNMcl9mMG1fY3FsdU1xSFdIODBGNWdMVlUtekUxUVFDbFVtZmpxVTF5WVdEblE0MTI0aFllWHJ2ZEM0UkhRcWNYRUdwbTlibUlJUzdPMmEwOUFRdWlTVXZGc2VMa0tvS3NaRXhRRHM4SGQwZGc?oc=5",
    "date": "2025-01-15T08:00:00.000Z",
    "dateFormatted": "15/01/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "Complete Response Letter, Warning Letter and Shareholder Lawsuit Follow FDA Data Integrity Findings  JD Supra",
    "company": "TBD",
    "types": [
      "warning_letter",
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "9ebfe06a74a5a5412272a687f48e36c6",
    "title": "Trew Balance",
    "link": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/trew-balance-709880-08252025",
    "date": "2025-09-09T13:00:01.435Z",
    "dateFormatted": "09/09/2025",
    "source": "FDA Website Direct",
    "sourceCategory": "official",
    "sourceType": "warning_letter",
    "summary": "",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 1
  },
  {
    "id": "d75fdbdbabd9027c30fb023ac4d24c14",
    "title": "Homeopathic Educational Services dba Homeopathic Family Medicine",
    "link": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/homeopathic-educational-services-dba-homeopathic-family-medicine-708635-08252025",
    "date": "2025-09-09T13:00:01.435Z",
    "dateFormatted": "09/09/2025",
    "source": "FDA Website Direct",
    "sourceCategory": "official",
    "sourceType": "warning_letter",
    "summary": "",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 1
  },
  {
    "id": "5773a6ab626757e9488cd4d6f3fda81b",
    "title": "Mel Honey US",
    "link": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/mel-honey-us-709535-08252025",
    "date": "2025-09-09T13:00:01.435Z",
    "dateFormatted": "09/09/2025",
    "source": "FDA Website Direct",
    "sourceCategory": "official",
    "sourceType": "warning_letter",
    "summary": "",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 1
  },
  {
    "id": "203ad6ea5f2064eeeec1ad02ebf25cb1",
    "title": "chillzoneusa.com",
    "link": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/chillzoneusacom-715556-08272025",
    "date": "2025-09-09T13:00:01.434Z",
    "dateFormatted": "09/09/2025",
    "source": "FDA Website Direct",
    "sourceCategory": "official",
    "sourceType": "warning_letter",
    "summary": "",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 1
  },
  {
    "id": "d29d04d2332ffd468a6f66e3be552226",
    "title": "Synergy Animal Products, Inc.",
    "link": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/synergy-animal-products-inc-712860-07162025",
    "date": "2025-09-09T13:00:01.434Z",
    "dateFormatted": "09/09/2025",
    "source": "FDA Website Direct",
    "sourceCategory": "official",
    "sourceType": "warning_letter",
    "summary": "",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 1
  },
  {
    "id": "9d71c21b047f32dc2ef2eb0668691118",
    "title": "Wisconsin Pharmacal Company, LLC",
    "link": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wisconsin-pharmacal-company-llc-710329-08222025",
    "date": "2025-09-09T13:00:01.434Z",
    "dateFormatted": "09/09/2025",
    "source": "FDA Website Direct",
    "sourceCategory": "official",
    "sourceType": "warning_letter",
    "summary": "",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 1
  },
  {
    "id": "a41e6167a82d171a3dab0f732ff06c09",
    "title": "Supply Center USA",
    "link": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/supply-center-usa-710859-08252025",
    "date": "2025-09-09T13:00:01.434Z",
    "dateFormatted": "09/09/2025",
    "source": "FDA Website Direct",
    "sourceCategory": "official",
    "sourceType": "warning_letter",
    "summary": "",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 1
  },
  {
    "id": "31161ea0554eccf6640672cce4b38e01",
    "title": "ejuices.com",
    "link": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ejuicescom-715645-08272025",
    "date": "2025-09-09T13:00:01.433Z",
    "dateFormatted": "09/09/2025",
    "source": "FDA Website Direct",
    "sourceCategory": "official",
    "sourceType": "warning_letter",
    "summary": "",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 1
  },
  {
    "id": "5431bb111285ca11e4cd74c2dd66f909",
    "title": "Chromatography Institute of America dba Compounder’s International Analytical Laboratory",
    "link": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/chromatography-institute-america-dba-compounders-international-analytical-laboratory-708944-08202025",
    "date": "2025-09-09T13:00:01.433Z",
    "dateFormatted": "09/09/2025",
    "source": "FDA Website Direct",
    "sourceCategory": "official",
    "sourceType": "warning_letter",
    "summary": "",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 1
  },
  {
    "id": "69d10419046d6d9c874e952b7478850c",
    "title": "Amneal Pharmaceuticals, LLC",
    "link": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/amneal-pharmaceuticals-llc-709894-08272025",
    "date": "2025-09-09T13:00:01.411Z",
    "dateFormatted": "09/09/2025",
    "source": "FDA Website Direct",
    "sourceCategory": "official",
    "sourceType": "warning_letter",
    "summary": "",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 1
  },
  {
    "id": "f06dddd6c1b85bfa898fda16f441852c",
    "title": "Staying Ahead of Enforcement: Executive Strategies To Prevent FDA Warning Letters - Med Device Online",
    "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOMlh0TnFnZkd6d2hLOEF3dUhfN1RKQmZQQ3J0UGl6SXdraUhiWXZYd2JZMVltRzRJRkZXUWQ0NU5ncE1UcUIyalVEcU1sQnpfQXdYZEdONzhySk9uMUJvakRGNmhtd0xYVGhMbXA4WnJmZ0RaWWF4ZE1IaVhQaEhiZmFrZEFUN0ZMcHdKdGxIdzdmY29qRHJpRXdLcGJ6VVFzWWgzd1J6VXdCWF9fVnZJdzdFZjZxVU8wMnRSellR?oc=5",
    "date": "2025-08-19T07:00:00.000Z",
    "dateFormatted": "19/08/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Staying Ahead of Enforcement: Executive Strategies To Prevent FDA Warning Letters  Med Device Online",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "38a23ad83a5f966f9dd9eac0510d9c6b",
    "title": "The Warning Letter Wake-Up Call In 2025: What FDA Enforcement Is Really Telling Us - Med Device Online",
    "link": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPSWFHZV9SUHFlSUYzbS1VQVlBdURxT3dXR0k5QzlYOF9fM3VzOVZ1S250V290cE9FQ21Oa1liS2VWZkliVlVRYUJGcUhJZVFpOE1pWTNpVHZXLUg1TTJSaVU2QlBpWVpTUkZJQmVVN0NsSDBnbDNZLVJZRTRodDRWV1pLZ1E0WVZUNVhuQmdUTFpxd0QwSWd4Q3p2SWlXcm5XMWRMQzFKODBteDZMS0MtRWNLZFV3MXpW?oc=5",
    "date": "2025-08-12T07:00:00.000Z",
    "dateFormatted": "12/08/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "The Warning Letter Wake-Up Call In 2025: What FDA Enforcement Is Really Telling Us  Med Device Online",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "4679789ac7d424e55daa06312a80bd9c",
    "title": "QuVa Pharma, Inc. Sugar Land, TX. Untitled Letter issued 06/18/2025",
    "link": "http://www.fda.gov/about-fda/fda-commissioner/quva-pharma-inc-sugar-land-tx-untitled-letter-issued-06182025",
    "date": "2025-08-11T13:13:34.000Z",
    "dateFormatted": "11/08/2025",
    "source": "FDA OII FOIA Electronic Reading Room",
    "sourceCategory": "official",
    "sourceType": "foia",
    "summary": "Task Description Request Please post to the OII FOIA Electronic Reading Room\nRecord Date 06/18/2025\nShort Title (70 char) QuVa Pharma, Inc. Sugar Land, TX. Untitled Letter issued 06/18/2025\nFEI Number 3012053582\nFirm Name QuVa Pharma, Inc\nRecord Type Untit\nState TX\nEstablishment Type Outsourcing Fac",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 1
  },
  {
    "id": "a457e4e176f617ed572b31b78d70c68f",
    "title": "How to Avoid FDA Warning Letters - Quality Digest",
    "link": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPUGFtcW8tNVkzQlRvell6cmZ6YU9IWlJYTkV4OHdINlcxTGRudlI1RnFLRWpXbjhYTU9fX25RbFd2UEp4dHRLcGQ2OXczNXE3eS1IWWhGMXVYRlZPS0xHOHZyVDYxQVdma19fSXBEYjhzSl9fSS1UR2dMLXJCREhReXlST2tBLTQxT2dDNGF4Z21SXy01UHZzN0R5Y05GcTI5a3Z3?oc=5",
    "date": "2025-06-17T07:00:00.000Z",
    "dateFormatted": "17/06/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "How to Avoid FDA Warning Letters  Quality Digest",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "1b70bbb7266d3b78f7c495b425582116",
    "title": "India's Aspen Biopharma Labs hit with FDA warning letter citing infrastructure, contamination and records problems - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPWjNlOVMwM2ZqWHVoYWFaRHFrYzd5bGlvNDZiTkYyTGNiaF9odWpQSGJ5RUIwNXI1RTUyRjhCZ2ZLeVVhLUdhRFppeE9XTm1RZjV5aWZTSjBrME9Mc210UXhTRzNFamlpWHYtdHFGWklpYm9qbklkdUFmSHF0NFN2RzhRaTY1T3JFNjlTSExackZHLXJMVVNYdl9zUmF1VldyS3dCNXJjVmpsZnJYZXA1a1N6dVdrZ3NUT1hGNnAxX1BzR0E?oc=5",
    "date": "2025-03-26T07:00:00.000Z",
    "dateFormatted": "26/03/2025",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "India's Aspen Biopharma Labs hit with FDA warning letter citing infrastructure, contamination and records problems  Fierce Pharma",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "70a397d04bd8607d69d68b12fbdbb7a4",
    "title": "Lytgobi Untitled Letter - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1hbkNVUXl3dGVocUdqdjhfYlFRcnl1ODBPaUFsbTkwRjRaelRCWVJmWjhTcFd6T2FqemZFOS1reTMwb1lpN0RvOWVlai0tdGF1VGMw?oc=5",
    "date": "2025-03-21T07:00:00.000Z",
    "dateFormatted": "21/03/2025",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Lytgobi Untitled Letter  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "4217616ef7ea2e02cd323e6b116bbec5",
    "title": "Dexcom receives warning letter based on FDA inspections of 2 plants - MedTech Dive",
    "link": "https://news.google.com/rss/articles/CBMidEFVX3lxTE1kZDFOS1BEdVY5c3h0X3NBWWxRdWhpUW1VTWRldDRSVXloWDAyUTdGUGZHcDZ0YlFhLVF6TF9vVndpaXVQR3gySWNKeXlFR0t3MG9mRU1uMzRQLXcxcngxbHkwZVZzV2FwekFnZ3JfeEdfeW1t?oc=5",
    "date": "2025-03-10T07:00:00.000Z",
    "dateFormatted": "10/03/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Dexcom receives warning letter based on FDA inspections of 2 plants  MedTech Dive",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "207fd6fbecd1fa696a9aff21b3f5f320",
    "title": "FDA hits pair of Indian API makers with warning letters, import alerts - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOcXZfQ0h3UUNRNHloVkowSHFBa1hyblNzMklrdGloN3NtakVTbDhlSjFVYXlxVzR2YmFVaVEyWWwzazQ4dU84RGxGd3hnYWxMVUFmNGNtbEM0T215cTEzd2NtSGZ6TE92b3ZmWGZyUlVkaHVQVktpRDBWWEx5R0lNNzh3ZWExX2NfR1o2OWw0dDlKZGx6bW9rd3BB?oc=5",
    "date": "2025-02-20T08:00:00.000Z",
    "dateFormatted": "20/02/2025",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA hits pair of Indian API makers with warning letters, import alerts  Fierce Pharma",
    "company": "TBD",
    "types": [
      "warning_letter",
      "import_alert"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "91f8e96c0530d540bb86ce51d7e49a0f",
    "title": "FDA slaps China-based API makers with separate warning letters outlining quality, testing shortfalls - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOckJqX1lIckFjTEQ1c3R3YWRlZnp4cVFfb2VtVVRoUC1SeTVMMGxFSGI3WEhXUUR1c0lVN0JHU2JKdGd0Zml6TjhXNy1wZ0hNME85d0cxaFZTemc5dXVTVS10RE9iN1FTUWprRWk0T0ZPRDR4Y3FIQWN5ZVM3Q2Q1dURDQzVTc3lhWVN1V0xxMTktRlhIM3VOSC1tdXNuRWR5UTh5TTBDb1VrOWx2bFpPOEV5TDRKRVVxSGJGWU5HSVJIajRt?oc=5",
    "date": "2025-02-11T08:00:00.000Z",
    "dateFormatted": "11/02/2025",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA slaps China-based API makers with separate warning letters outlining quality, testing shortfalls  Fierce Pharma",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "7bb8e525887cdf78e01bab388e1eaead",
    "title": "Hemady Untitled Letter - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5kdEExSnlhODhtc0RISHdGRFNuZjlyNHNRUVcweUFTNmltY1BzXzlmV05qZkU3S1kydWwzWWEtb3BQLTNVTDQ3VnB5aFlJZFNCeU5j?oc=5",
    "date": "2025-02-03T08:00:00.000Z",
    "dateFormatted": "03/02/2025",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Hemady Untitled Letter  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "5070cce26f21bbce567b944d63abc23f",
    "title": "FDA warning letter reveals quality control, data integrity issues at Viatris plant in India - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNLVZtZVpSekVIb2VmQXJFQzJNamNBc3Z0ek83MkNMdHp3cHlhQjhuN0NIVlFNR1pxX25FR2xkNG01X0R4cjdINUNSZGZCd3llem5fWjl0S2xHVlRVaDdjYzFoVWRjYUFhRnc3alVPa193RWVNY3BjZFVzOVQwNDQ3VkVJNUVpSWNpcVNtT1A1cDZJakVqbm4xdWZtQnVJMUJETE4yM2VtRDJrdUVwWVRJQ3FNcHpCcTBteUtZYld6Vjk0Zw?oc=5",
    "date": "2025-01-06T08:00:00.000Z",
    "dateFormatted": "06/01/2025",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA warning letter reveals quality control, data integrity issues at Viatris plant in India  Fierce Pharma",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "4b492b7ecb665d2efbfa411267f81241",
    "title": "Viatris says India plant hit with FDA warning letter, import ban on 11 products - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQU1djX0V1eHMxNzQxTnRva3Zhaldfa2VxN2Z3ckFTS20waFh3TlhfQ1ZoMnlod3pKZzJRSzdZZFA3WUhlWjZ6UlBub01SRFNyc284aTJPN0xNS3locmtnamF3SkVSSEVLdTFXOFRLTF9sYkYzYlNlQkJoY3JNS3h4R0RfY2Y2ekhsVnc2eW4zQ19wRDBrN3MtYW5laWVNTXE2N2g1RHVzaE1aNkdWWXc?oc=5",
    "date": "2024-12-23T08:00:00.000Z",
    "dateFormatted": "23/12/2024",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Viatris says India plant hit with FDA warning letter, import ban on 11 products  Fierce Pharma",
    "company": "TBD",
    "types": [
      "warning_letter",
      "import_alert"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "a9ea0884b713e9b55d7fa54412db10e3",
    "title": "Krazati Untitled Letter Close-out - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9qUEFwVmhXTDdZVjZqSmRXU2NwNk45MlpFTF9JQzdGeEFwUU9CQXJXS05tMGxMcTRRUXhlNEc0Q1NpMmZKZGVMTTd2VndlcVlUc2Yw?oc=5",
    "date": "2024-12-11T08:00:00.000Z",
    "dateFormatted": "11/12/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Krazati Untitled Letter Close-out  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "f824c6a5f0514f3ed949fff22386fb4c",
    "title": "Xeomin Untitled Letter - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE05S0tqazhsQklPTVhoYm1sVWVISXJoQXVjUFhETWlpTHZlMDR4R3pJNENqS2pCWmRtcmZRUlQ2MDRjbzk1dFR1Q1pDUVF0bDROeFo0?oc=5",
    "date": "2024-10-31T07:00:00.000Z",
    "dateFormatted": "31/10/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Xeomin Untitled Letter  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "ee901a23389e6f139645993190d94b6d",
    "title": "Ubrelvy Untitled Letter Close-Out - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1KRUhxeG5PM0xrZHRsQnQxOFYyc0xQNWNUNVdmYjB4MzE3OGZHZEsxV1BxQjRYenptTnNleXpNYjUwelo0OUdQVk9ET1lQaWxCc2U0?oc=5",
    "date": "2024-10-30T07:00:00.000Z",
    "dateFormatted": "30/10/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Ubrelvy Untitled Letter Close-Out  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "e032311b38e640cde92cbe6a4d198241",
    "title": "Auvi-Q Untitled Letter Close-Out - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFA1NzJybGdldjd1UVhCcmlrOGtieU1wTEJPUlFtR2hYTHItQTJER3VXNXJjeDMtVWlUbGJHcXpoclZjV0pqcUVGSTRlVHI5R0JwazNB?oc=5",
    "date": "2024-09-27T07:00:00.000Z",
    "dateFormatted": "27/09/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Auvi-Q Untitled Letter Close-Out  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "1251cff4ae08b3b7d475d522aa409b15",
    "title": "India's Zydus hit with warning letter as FDA flags glass contamination concerns and more - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPdUJnWl9iUGV2TDhjaVVORHBacVJMdlFzMUYxQ0tYWFJucGdxNE5hQU9NTWhYNUxub21pdEpzTF9CeWMwcldpd3h1a2tyanY4U1d1VVBJSTFpNVdiU3h2QUdTOTFGMVZVUmVLS2MtYjREMTZQdWtXV3hubkRwLTh4RjdEclpDcmhST01FQ0lleVhkdkw2NzJpc0FGUjNoenVfSVp6ZWdKbDhLRVhhSERNcE9oaw?oc=5",
    "date": "2024-09-11T07:00:00.000Z",
    "dateFormatted": "11/09/2024",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "India's Zydus hit with warning letter as FDA flags glass contamination concerns and more  Fierce Pharma",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "5e44d9575afbe9deb904e2945dc66a99",
    "title": "FDA scrutiny of India’s Zydus results in warning letter - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPRXZjSjVUeGNPbmx2ZFRReEFsTXVwcF9UeU1janhzR1g1LWdaV0hMRGtoaVdUUVhUYldkdU1iekxmUU5Fd1NPeWZtOW1YVTlSWDh1NlRKZW1lb2N3YVNJMFZfRmZ5ajNmR3RfaDFYS3hNb2RsamNuMTZiRjFrQUJlMkNjVEJFNjVsWGNGMGpFMWp2RDhMRnc?oc=5",
    "date": "2024-09-03T07:00:00.000Z",
    "dateFormatted": "03/09/2024",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "FDA scrutiny of India’s Zydus results in warning letter  Fierce Pharma",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "fdec0c54d4df1ab91ada32cf85df04a2",
    "title": "Untitled Letter for Ubrelvy - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9yalJfd1ZKUUZ3cDNKbjZCdjlxb3kzZEgyWkVuLXM1UGY0UWRNS05fM2c3Zk1neXFCT1JuVDI5bllBNmJTakZSLWRvdGJQNzMyekI4?oc=5",
    "date": "2024-08-29T07:00:00.000Z",
    "dateFormatted": "29/08/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter for Ubrelvy  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "f41717ca2dd7d00148053c1daa975701",
    "title": "Untitled Letter Krazati - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9lRk91bnpySjZ5ZnJEQWlzOHNxSm9uS01BVGVrVVFuZVJhTGhVYU1XYXpCU2VrclZCcnRMZm5rSWc0aktIMHZiZ1pLWDRqNWExbXdZ?oc=5",
    "date": "2024-08-01T07:00:00.000Z",
    "dateFormatted": "01/08/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter Krazati  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "09137608b6f5221028060316d988c836",
    "title": "Untitled Letter Auvi-Q - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE12dkF5Vl9GT0NTeFhHNHNmSV9hNDZCUnBkSWlzazRBWUtVcWs0LV9KUjVlTmwzdUxkX2R2a0xUOFhZWUhXdXRQRkpsZllrblRpRHV3?oc=5",
    "date": "2024-07-17T07:00:00.000Z",
    "dateFormatted": "17/07/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter Auvi-Q  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "4e1da7877efdc329b342dd3f4b1d14d9",
    "title": "FDA Issues Warning Letters to 14 Online Retailers for Selling Unauthorized E-Cigarettes - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPdU1HSlNGLXo1dVlyX01Ub1Bqam9zNUcxc2lncU9oOWVOdkE2WXhRT3Z4eEhRQWRUU0RxUTBWbEpSUmtkRFpkRmo5LXRUT1BVRmtNRG1mOF9wSE5aLVNQYkxPNjhDYy03d2JEdlRfZ240ZkVLUGpHbHMxTEx1TEN5NEprRGFmZXIzX2p6eTZjSnU1LWE0SXEwVS15MXZHcWcxSnRTVHdnLUwyZ25SS2F0Q1hUaEFMcWRYSWJIYlR5NUlYaE1LT1N2WGNn?oc=5",
    "date": "2024-05-01T07:00:00.000Z",
    "dateFormatted": "01/05/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "foia",
    "summary": "FDA Issues Warning Letters to 14 Online Retailers for Selling Unauthorized E-Cigarettes  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "76aae865e33844afd984b1cb1a4dffbe",
    "title": "Import alerts, warning letters, drug recalls — why ‘pharmacy to the world’ is facing US FDA heat - ThePrint",
    "link": "https://news.google.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?oc=5",
    "date": "2024-04-23T07:00:00.000Z",
    "dateFormatted": "23/04/2024",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Import alerts, warning letters, drug recalls — why ‘pharmacy to the world’ is facing US FDA heat  ThePrint",
    "company": "TBD",
    "types": [
      "warning_letter",
      "import_alert",
      "recall"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "384be62c09a59d66d6e7c1506981f252",
    "title": "Kisqali Untitled Letter Close-Out - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBDbGloT2FuMEozdXVocG9JVzJSNU5MR2E3TDdNN1R3YjE0S1JJNEZPNTR4UlBYY2p6aWJlcUxLYTlVNkJmYk5GVnJXYjlKX0M2MU53?oc=5",
    "date": "2024-03-15T07:00:00.000Z",
    "dateFormatted": "15/03/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Kisqali Untitled Letter Close-Out  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "4b0579a6b71507b2250321866a84a60e",
    "title": "“Modernized” Food Manufacturing Enforcement: Trends in FDA Warning Letters - Food and Drug Law Institute (FDLI)",
    "link": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNdkRnbllwMnU3bWxjaWFEOEE3TV9hT19oQ2RlNkh0OTBoTzRiZG01clZsWVZfWXB1UHk2SjNOUkNUSEpBcnBJdlB1YjByU3VISlpnY1ZIYWJwMWk1bHJqeUdaQl9CeEE5Q052cXp1dkNPWGV0M09NQ0UxZjEweWtQanZZTGNVN1JtZi1SSDhHZGx3eGx6cGdOQWJhV1habmc2VUFR?oc=5",
    "date": "2024-03-08T08:00:00.000Z",
    "dateFormatted": "08/03/2024",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "“Modernized” Food Manufacturing Enforcement: Trends in FDA Warning Letters  Food and Drug Law Institute (FDLI)",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "491890649bede63c5f25b7bfe0b68780",
    "title": "FDA unleashes multiple warning letters targeting insanitary manufacturing and online sales of unapproved Mounjaro, Ozempic - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPaV9WcHBaQ09CSjBXQlpDMmJyVm9SX0hhU205NlRNUlhNNzFYR3dMcWt3OTRoLUdYd1VlVGUxclNTV1B2N0o2djVIcllXQUgxWEhvZGNsckh2ejNoeFdab1E1c3F6ZXY4UU4zcXpyUTJZUTJFSGJTc3Z0OGlTWF82Y2tOMWFRZTlwaEdDOFJuaU5lRnY4SDRTelVaVnNTX1VrZ2xaU1lDd2tLS2t6RXZMeWxab1hiT0NzcW9JdDlYSm91TlZ5?oc=5",
    "date": "2024-02-14T08:00:00.000Z",
    "dateFormatted": "14/02/2024",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA unleashes multiple warning letters targeting insanitary manufacturing and online sales of unapproved Mounjaro, Ozempic  Fierce Pharma",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "899bd9b1ae0dd04c923e3f3a15fb4275",
    "title": "Issuance of Untitled Letters - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxNUEVmaE1sTE92WWpYLXUxSjE1ckxTR2NMbXVVNUNKS2lzTzVVOHpoVHJ5bHpIZDFMNjNLSjI1ZTQ0dDVRbVoydlE4LW96SnVFd2oxalJnM0VGYTdQOU1VR2lGX1k5TWo3UmVUa1JGZWt1bllOcVVRbjZuVFNrUzJZeWZDc0lIbE1VYUhHTTNaOTdYODd4b2JPTE5BQk52NFpKeWV3eW1acTU1Uk1zRUMwS3huR0E2TVlOV29URTl6SFlvbjdZRWJTR0haX1gtZFhRRTZaZndBa2FWQQ?oc=5",
    "date": "2024-02-07T08:00:00.000Z",
    "dateFormatted": "07/02/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Issuance of Untitled Letters  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "8ac72e3103123bd55f98e1caf3f5bb95",
    "title": "Untitled Letter Kisqali - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1ycENkVW5IWnZVcVNjZlJ5UGJXOXp1dTkyWUxaelNrXzJsTV9xUnFENDgzNExLcmdkQUV4QlVpMVIwWmVkcTVWbmRSNDU3WnBzc0hJ?oc=5",
    "date": "2024-01-18T08:00:00.000Z",
    "dateFormatted": "18/01/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter Kisqali  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "d4a507caf32664a8f0004e014e027caa",
    "title": "Untitled Letter Close-Out Phexxi | January 2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE81dnlKMHUxSko2dFcxZkp0U3c0azd4WGVfQy1Ecmo1aXFsSWJNSkJxUDdPeW9kd3FHV1hDMHl0RGtKaXgxa2xDdUJaMHlLd2p3Rkl3?oc=5",
    "date": "2024-01-05T08:00:00.000Z",
    "dateFormatted": "05/01/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter Close-Out Phexxi | January 2024  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "b70cff01e3ccd6bd21659fd648f825ce",
    "title": "Untitled Letter Close-Out Rexulti - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBDNENpUzJxVnNRYUVhSkM1bFduRUNxXzlRVDlIY00wdWJtejJNbjBPRXlxVGcyN1YzMEhsaWhSc25xQl9oNTNKRlcxeFNQeWVHSnY4?oc=5",
    "date": "2023-12-20T08:00:00.000Z",
    "dateFormatted": "20/12/2023",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter Close-Out Rexulti  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "284b12368b65a0b238f911956ca3c10c",
    "title": "Intas Pharmaceuticals Hit with Another FDA Warning Letter, Put on Import Alert - BioSpace",
    "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPVVRudEJxcG1NTnJ1c2phcm5nQ3ZDcGRqXzVEeXdXclJMMy1Fendobk1WamNBNDFrZHZRQU9LNWFrRE92TWpUbEhvSS1FTWJCRW9YNFJnamZxN21xcF8tVmdkeFhuNjdyYnpUYkhSaTlTR1YzT3pWSEZnMkNuVWZvWTZsS1M0RkhnRjdjTlJiMG1WMjQ0bUxmMHUtQ05scHRONzVhaQ?oc=5",
    "date": "2023-11-30T08:00:00.000Z",
    "dateFormatted": "30/11/2023",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Intas Pharmaceuticals Hit with Another FDA Warning Letter, Put on Import Alert  BioSpace",
    "company": "TBD",
    "types": [
      "warning_letter",
      "import_alert"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "5c79efdd55de5e960040e2a04a3dcedb",
    "title": "Intas on import alert as FDA flags data manipulation, management failures in warning letter - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQLWJaYmJ6bmdjMDU1ZHl4TVU4eWxtcFZwVUhaZnQ2M1BmOEphQ1JFRE82V2NZamFNNVNPUHBNcmZvTDFHbEJkV3NKbzJBN25PTVlaZ2N6OTFZalFmYnA5ai0tcXFnVklLWEtmVjJDRDVEa19mQ2tSMkJQbkhPbmdKME02dWEzc0tfVGVZTU5HbVotTnQzc1A3T3luNkdNbjR0LWFYVnYzUjJ1U1BBZ2s1Rw?oc=5",
    "date": "2023-11-29T08:00:00.000Z",
    "dateFormatted": "29/11/2023",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Intas on import alert as FDA flags data manipulation, management failures in warning letter  Fierce Pharma",
    "company": "TBD",
    "types": [
      "warning_letter",
      "import_alert"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "ec649b964db0fc90307d79c85239d72a",
    "title": "Untitled Letter Rexulti - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE01TkNQOFZyTXprWkVONXVtYnpiWk03TkMtMnNoUGNJZ3hxSEl6V09XTUtfczJMUFZxMFpwRHFjdFBJWnE3M3hpOVh2Nl9WZURUZjZJ?oc=5",
    "date": "2023-10-31T07:00:00.000Z",
    "dateFormatted": "31/10/2023",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter Rexulti  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "f09cbd3f74388fa2dec3228d143c1e93",
    "title": "Untitled Letter Phexxi - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9TdV92Slg0Sm5rYVdQT2RUQk1VeWVQaWxpLURlQ0E4YURvSjF0YmVOQ1dnaF9DbnhSbEI2dzE3eXNRTDZaTW1iZ0xNXzBTeDNNTm40?oc=5",
    "date": "2023-10-31T07:00:00.000Z",
    "dateFormatted": "31/10/2023",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter Phexxi  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "34a272a0ea3bde87475e44b0044d5d4e",
    "title": "Office of Prescription Drug Promotion Untitled Letters - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPbTF2UUdtQmpZempPSVVJZlhlS1BMMmQ4ZHdCRkpVT01KOWJ4ZEpoX00ydGxLcmJTemZTZGRzRFpMQUNaY09ZZ1FHNzFNNVBjUE92ZFNwYXNVRlNuR1pXZFQway1POGhUaTFOcDY0dElHN0Rpb250TDRsM1hidThXb1JPYXB6MmxUc0dQQ2JsY0xuR2VWT09oUG5wemJIS2FJMndUZEZqcTFodXd5YkJoSHZR?oc=5",
    "date": "2023-10-25T20:05:34.000Z",
    "dateFormatted": "25/10/2023",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Office of Prescription Drug Promotion Untitled Letters  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "50bd028dfa44294808773d0cb7abac96",
    "title": "Warning Letters and Notice of Violation Letters to Pharmaceutical Companies - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQOWhBYlN5dHpxRS13ZXBES2QyLXVfRk90WDBxY2pjSGFBSW5Za3JJN2pVNHJORjVRdmRWTXBGLXFpOHE3WUxjU0hzOW43V04tMjFxUWRoUjBsMk1CdWVuZzhVRVd1VHZkNkZaUW5uN0o0QkszU21KMVRLVUYwaDVFLWJzNWt2c2lTa3h2eUhJQnJ0Sy1CQzVvQ0JpQWRMR1JnRWs1QmlvalhNWXp5ZHlBMFFGVy1lTGNOb1l4RUFscw?oc=5",
    "date": "2023-10-25T07:00:00.000Z",
    "dateFormatted": "25/10/2023",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Warning Letters and Notice of Violation Letters to Pharmaceutical Companies  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "758e25c6a9aee9db8d465f39a18384e7",
    "title": "FDA Issues Warning Letters to Firms Marketing Unapproved Eye Products - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOc1VHNmJUR3dFN2lEMWtTeXF5eFduR1hpclZHd21OaHJVXzNKNFhucXdIS19LYng4cDNMMl9jd0pibXpleWFDc0Y4ZHJoSE1WUTBrdUYtcUpIZ1RjUU9iX3dqbEVNRDgxYWNjVDNXaHp4dk9HZmVYSjdrQUw1aUNqS0JYdmk3TnFKal9xa0NwY1gxLTNuN0xtdVJPN0ZPbzFOTTVJZVBpMEFvcFNjVVhBU2lwQUNCanVwRUE?oc=5",
    "date": "2023-09-12T07:00:00.000Z",
    "dateFormatted": "12/09/2023",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "foia",
    "summary": "FDA Issues Warning Letters to Firms Marketing Unapproved Eye Products  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "82a69502df44fbed33e6e954baa7253a",
    "title": "Untitled Letter for Slynd - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBtUmZzU3BteEN5WktDRHJSYU5YNkMwQzIzbUQyY1lUSHhfZGtERnZFMkZVNl85cXBEUWJIR3NmYXRGQXIzeE5UM3NSUlU4LXhDdnVZ?oc=5",
    "date": "2023-08-11T07:00:00.000Z",
    "dateFormatted": "11/08/2023",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter for Slynd  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "b2550dc88362c48849173752c1374060",
    "title": "Untitled Letter Close-Out Recorlev - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBFNk5wOW1xS2JHYVBUTFhNWFBqOHY2el9QR2tYVUx0WWtPUGdDMUZMN3hDRWMwM2FnSXdsVktrQkU3QUNZeko5bmlfcnNWQTVWcjFR?oc=5",
    "date": "2023-08-09T07:00:00.000Z",
    "dateFormatted": "09/08/2023",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter Close-Out Recorlev  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "811036f296cf991fef16ceb2138e115a",
    "title": "Untitled Letter Recorlev - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1JY2dLc1UwLXlWakpqZUROeVEyU3BFaG9oYkNOelZOblh0eGo2S2xGNFNnaE0xdDN3Q2Y4Sm9QZW9senl4NDZ0NDBTQk9RMGRLUFQ4?oc=5",
    "date": "2023-07-06T07:00:00.000Z",
    "dateFormatted": "06/07/2023",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter Recorlev  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "8b125b49c3537573e5a5e6fec6bc9b42",
    "title": "Sun Pharma facility under an import alert handed a warning letter - Endpoints News",
    "link": "https://news.google.com/rss/articles/CBMikwFBVV95cUxORV8yakNTNHpLTi1La05mSEdOSFYzZkw4Q3EtUXlzcDAzdGxhTEpiRk5vbUd2WEVmYVd6N1FMdmU4RlJYT3BXdjRXTldna1k0bVphLXJObzlyTVFINldjMHI2dkFtUXdiOEJsWnNVTGxtQjlScnRaMk9HUnU4YlZOc2tnby1YWHZ6MWlwdUEwQ2lQckk?oc=5",
    "date": "2023-01-11T08:00:00.000Z",
    "dateFormatted": "11/01/2023",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Sun Pharma facility under an import alert handed a warning letter  Endpoints News",
    "company": "TBD",
    "types": [
      "warning_letter",
      "import_alert"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "95a5878d47ac402cd67aee34da475ddc",
    "title": "Mexico's Glinsa suffers warning letter and import alert after refusing FDA manufacturing inspection - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPY1NQeEVCRFFGMGdOQXg4R1E4T1pzYmFucmZFZWthX2pvY2I3RTkxQktHTlNSWHRNc2pmbGpEbmVIYUxXUjNlN0tnUFkzTUZLMXRfUDFjUENlclB6Z1hsSUhOcV9fQVlPR09iOUl6d1hoY0ZTLU9HYWVJTXNFNFRUd1ZRMTZGVDdDaXN1cFZpMkVKNDNtNjdZOHBGUUFEa2htYkNBN1BzaW82R0J0eXl3QXZjRnZpdEhFX3pKSGRCbU82N3dC?oc=5",
    "date": "2022-06-23T07:00:00.000Z",
    "dateFormatted": "23/06/2022",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Mexico's Glinsa suffers warning letter and import alert after refusing FDA manufacturing inspection  Fierce Pharma",
    "company": "TBD",
    "types": [
      "warning_letter",
      "import_alert"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "e9cc5abb95b9115d3ec37c36d45995de",
    "title": "Untitled Letter Roszet - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE95R1JUMkZWRmxNU2QyalV1bkgxd1FXdEoyQWhxcGZDa05PUDVkMWp2VF9GVDZMcUZtLTJhY0gweF9tRm9iZm1pU281QUxod3ZrOFJF?oc=5",
    "date": "2022-06-02T07:00:00.000Z",
    "dateFormatted": "02/06/2022",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter Roszet  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "40ae9925125820f4b96a45e9b4955592",
    "title": "Untitled Letter DUOBRII - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9yeUFKQVhWNzItMUZyV0lmUkhOM2s5dTVNdGxmTW5qSWM2NE9lSFB5ZVl5RUVIZGZQdkE3WjFua1dIS1daRG5XTG5EX1RzQXdYclBJ?oc=5",
    "date": "2022-03-31T07:00:00.000Z",
    "dateFormatted": "31/03/2022",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter DUOBRII  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "b112ba5be88004510dc253c9572d949d",
    "title": "Untitled Letter | NEULASTA® (pegfilgrastim) injection, for subcutaneous use - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9jT1pjaC1aWVJPSS1FdEQ3SU9aejhsdDJuTGlXRy1ESFBDUWhVSWVhWHdUZEZHTmdsbzRFQnRLMEdEcnp4RTdMWmljX0tlc3k3ZEI4?oc=5",
    "date": "2022-01-11T08:00:00.000Z",
    "dateFormatted": "11/01/2022",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter | NEULASTA® (pegfilgrastim) injection, for subcutaneous use  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "62713487c1ac1c4311d7f916befe1c45",
    "title": "RESPONSE TO UNTITLED LETTER | EMGALITY - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBlbzNtdXNnZEJLaWlwNnVWVXBWSTd2TlRaa2w3eUpFbzJDazVvNzJEMlJZcmZyTHFtT09ybDVrQUJnbGRKX0kxQklzeXd3UFVrWTgw?oc=5",
    "date": "2021-12-21T08:00:00.000Z",
    "dateFormatted": "21/12/2021",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "RESPONSE TO UNTITLED LETTER | EMGALITY  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "8eb521347cedfadbf16efca6acea79db",
    "title": "Emgality Untitled Letter - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBfN0szeDVZTG1TRXNKa2FhRTJkUFhhTnhmejFKa1Y1NjhYMzZRUnJ5TmI1NFR4MXM3UWxad0R5TW9VM2UyUU1fUW04Z0JtUFNJUlNV?oc=5",
    "date": "2021-12-13T08:00:00.000Z",
    "dateFormatted": "13/12/2021",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Emgality Untitled Letter  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "1a35fd1deb63f1a3090c1734812d2e23",
    "title": "Untitled Letter | NURTEC ODT (rimegepant) orally disintegrating tablets, for sublingual or oral use - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5DWWhZUVQ2cldOTDdFb2tKRUl1TkhrUmdteHYwYTJIdGhzRjJXMHhNUmMzZ3ZVY3laOGppYnVqZlZWdWdNR1VNaGpmazB5Q1J1V3pR?oc=5",
    "date": "2021-11-19T08:00:00.000Z",
    "dateFormatted": "19/11/2021",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter | NURTEC ODT (rimegepant) orally disintegrating tablets, for sublingual or oral use  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "257337a645431dc9db793aaca9ee18fa",
    "title": "After triggering a global valsartan recall 3 years ago, Chinese drug manufacturer overcomes FDA warning letter - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNTktObVVMQXZ2QlMwWVlVNFBPakZkSEVwTDMtaVFPalBrQVA1dDhfSHpobnVMWG1JcFRCSXJubkFFRUtQb2R6UFEtaEJXLUVodnRySENkNXVvNjAteUg0NUhldmVDN3h4NlowTm5PbmxkYTlRS0dIUmlGTjA3RU90Y0tSWEtEaGN1LWsxSHJPaXBkbHZ2WmRmZzAzd0FHaTJ5X3BXeE1XQnpQV0IxbnRlb0xIdHdLa2gwRm5vaG9uMlptZU4t?oc=5",
    "date": "2021-11-15T08:00:00.000Z",
    "dateFormatted": "15/11/2021",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "After triggering a global valsartan recall 3 years ago, Chinese drug manufacturer overcomes FDA warning letter  Fierce Pharma",
    "company": "TBD",
    "types": [
      "warning_letter",
      "recall"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "b144e7a3a44d2fe8196e1e02659363d1",
    "title": "Untitled Letter | ALKINDI® SPRINKLE (hydrocortisone) oral granules - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBtX3doR00zQVlRWGVTLS1mRXNMTDlIZWJSZ1p3RWdLS3RiU2JkLXphQjB0VFhTeWYzZEVSTlNtd29NTjJ6WExqMFpDYUFRRmlDVVdz?oc=5",
    "date": "2021-10-04T07:00:00.000Z",
    "dateFormatted": "04/10/2021",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter | ALKINDI® SPRINKLE (hydrocortisone) oral granules  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "cd89d143cd92e44d34afac07ab6fa8cb",
    "title": "FDA warning letters detail violations at China, Mexico drugmakers already under import alert - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPdG5panZOR0dXUjZrbUh4VjM1c01NNnB2NzNvdHZzMWdiOXVHQm5tQVdJMWlneFJTSHAxUHppQU9mSWhQNlc5SEtTOERuMGo2Y0dORmRoYXBTMl9yNGMxaGt6bm1YNVBJN2RoeEpjc2RzNlBocmJlODZrOGpnYmdNSzAxUVFvMTd4UlpFeHBMem02SGxQS2hqbEdfb1NxaTJZTmNrSWVLOA?oc=5",
    "date": "2021-03-17T07:00:00.000Z",
    "dateFormatted": "17/03/2021",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA warning letters detail violations at China, Mexico drugmakers already under import alert  Fierce Pharma",
    "company": "TBD",
    "types": [
      "warning_letter",
      "import_alert"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "bb03a712d54fae0e693ea85b361fec9e",
    "title": "WARNING LETTER - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBYTFRCbFBpYnp2c0JLSDhwRThuajFFZjF3Z0ZtTDl3Si1TM3k1RW9VdDhQcUQ4Q1ZYRDRyd0lqZ1JYdjZyenU0aFZpOWV5VEc2c05F?oc=5",
    "date": "2020-09-22T07:00:00.000Z",
    "dateFormatted": "22/09/2020",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "WARNING LETTER  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "3d69d5327aff419b3b790eccf23edb50",
    "title": "WARNING LETTER - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFA3eGJVXzVDSGxHclRKYTRqRDFqY1dVZE8wcEJTb1FIWW5QSmYybTNJam9vUjRKOUNjaVluRlRYeXlQSHBkNmVOTG94OFZJVnoyTTJF?oc=5",
    "date": "2019-08-16T07:00:00.000Z",
    "dateFormatted": "16/08/2019",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "WARNING LETTER  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "c2bbdb5879256ed9ecd4676ff328f27e",
    "title": "An Analysis Of FDA FY2018 Drug GMP Warning Letters - Pharmaceutical Online",
    "link": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNQV9IQVAxQWhXZnh3ZUN3cWl0aFlWZjNIN3ZmRmNfRVExM0R6U0lWbEk5R3A4OU1sN1BrWDdYazdnLXoxb19tTmJRdWtKUENVLWNnM2JiVXJYbmRRMGV5MFFFYVhFcEVJNGNlSGhMWXZVTVBxTG9fZHVyWERxb1EzNEE3aER1VkRtdnNkbldxdU1fdTNrVGJz?oc=5",
    "date": "2019-02-01T08:00:00.000Z",
    "dateFormatted": "01/02/2019",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "An Analysis Of FDA FY2018 Drug GMP Warning Letters  Pharmaceutical Online",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "4acc52494343f22963a3d1950a121b4f",
    "title": "Dear Dr. Woodcock, I am writing to bring to your attention a Warning Letter that Vanda received from the FDA on October 22, whic - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE51ZFIybzZCOG0tY3oyWVZrTGpDbEhkODNncUNYYXI0dWU4bDI5TnZYMzFYQjh0eWlNNEV2Y0lGMVUzZ2JTYUVkczE5RTJjM0NGMWtB?oc=5",
    "date": "2018-10-22T07:00:00.000Z",
    "dateFormatted": "22/10/2018",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Dear Dr. Woodcock, I am writing to bring to your attention a Warning Letter that Vanda received from the FDA on October 22, whic  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "99871369968fe8065921fd20ccab3484",
    "title": "WARNING LETTER - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE10aThhZ3k1N3pKUE9xd1JhazU2dUNaQmlLamxmeWFmZGZKeFZCbGFNYzVYOVJUSFAtVlV3LTI3ZThaejBfYTVMS1hrRnl5ODF0Qzkw?oc=5",
    "date": "2018-10-22T07:00:00.000Z",
    "dateFormatted": "22/10/2018",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "WARNING LETTER  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "ca0d8d21914a08a103dfee4f13fdb317",
    "title": "WARNING LETTER - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE50czRfM05aa2dzMmluM3E0ZVg3T0cyaGppcFczeEZRalVrVWEtN2RlSkJEblFmVGRrTkdjTXlLbURkMXFXcG5BUlN4WUNsMTdVTXEw?oc=5",
    "date": "2018-10-05T07:00:00.000Z",
    "dateFormatted": "05/10/2018",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "WARNING LETTER  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "85db6ac8b28a951100b9abb829733ebf",
    "title": "FDA warning letter tells India's Goran Pharma to get professional help - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOcnVvdlRNOGt2dV9pa1lvS0VvT1VIQ1U2OVhXMFRUV3J6ZWJsS2RsbUdXcVo3MkNGVndBa3JCc0g5UHJrUzR0czg4TTRLRkhRbVRRSkJaN1RZVTJ2RDVvZ2JURFVRZ1NfZ0xvMDJGTjJhMkw2QnkybFNWbWN5UlhTS1hSSmstMDU2anQzQVBMYnBxYmQteEFLTWR4TndNNWd1Sk1HWDRDVlJLaW1sano2MkxHUQ?oc=5",
    "date": "2018-05-10T07:00:00.000Z",
    "dateFormatted": "10/05/2018",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA warning letter tells India's Goran Pharma to get professional help  Fierce Pharma",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "c6d5a7b95604fbab2d837876a139605a",
    "title": "FDA hits Dominican Republic drug manufacturing plant with warning letter - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMirwFBVV95cUxONF8yZEliV1J5b1EwNm1ISjc5YUF4VjhSTVdURFdKaDkySEZManc2Um5ic2g1R2ppU2ZTUkUtenlDWlFBemxOYWNDNDJHV0NnSTJxTm13NTZvdUhQRURleko0em9YaDdCWGU3aDNYSkdsWl9WdWJEcnBuQ3lfbWFHWHFNaUJGX0UtWjFnekNmRzg2dWN2U0dhd3hNWVVRS0JrZGZibk1CbFN5S0tmbnJj?oc=5",
    "date": "2018-04-03T07:00:00.000Z",
    "dateFormatted": "03/04/2018",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA hits Dominican Republic drug manufacturing plant with warning letter  Fierce Pharma",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "d2ce75a55016dea35526ba7626316853",
    "title": "February 27, 2018 Untitled Letter - IDELVION - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPTU1UV1RVdjlHbENseVIwTXJKdnBHTEtpM1FTUWp1cUd6OVR6d2k5Xzl0RV9FM2xZdEtDT0d6SjBGdEFTbkNWUkxYYU9DdWdQRDdqdFVWamFRWDdYa3VHeWVueGdsNjZrR3RmM05aZk81ck1HOHlGbEFxTmt4UjJOR0N4dVBTSGR6TWVnOWdyU0dJbUxJdUJyRVdFSHJzSVJHamxNMS14cVp3NWRNVFA4c2h4ZEZLMVIxc0Nsb2VOdw?oc=5",
    "date": "2018-02-27T08:00:00.000Z",
    "dateFormatted": "27/02/2018",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "February 27, 2018 Untitled Letter - IDELVION  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "998646e8a54de30419a4145d5c3920f2",
    "title": "Lost in translation, FDA slaps Chinese drugmaker with warning letter for mixing up APIs - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPbXdmN25YWDA2MURzYkhXMFNNS2YxVWRBdkZxQzBHb19oRWxHRklyQ2lJT1NwSXFvZVM3ZWtoTmNHMjc1SUJaTGZUWl9IOHYtLVZrZW9MZ1FPQXVXWVgwMEtSSFBsVXpBODhpcl9TWG1MejA5TXBjNV9WMnMyOXYyNDlBOXVabEpMU3RQVXl3dmktM1VYYVIxank2LS1EX0tvQVJHOEhGWVR6OWRmMExKbDNNUXZJRUdvRS1KVFVn?oc=5",
    "date": "2017-11-08T08:00:00.000Z",
    "dateFormatted": "08/11/2017",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Lost in translation, FDA slaps Chinese drugmaker with warning letter for mixing up APIs  Fierce Pharma",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "07fa321faf914fe474bcc3cccdca5ce4",
    "title": "South Korean drugmaker slapped with FDA warning letter, import alert - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNUFc1MzVUdUdrNk5Ud3hFMG5qTjhrdW1uMjlocWRleTZydExIU1RidmRqM21ibjFwUkh1VG5DRXNGYzF1MUh5UmhIZTZrYnBKUEEyaGFidHExZUlTVDNNdVFJWllMZnVMQlBYTEZIbWowaGw5bjJjU2RyNVZMQkJIWUItTFV5MUdTY3hrc1dYS05BRVdXRDRHbTFfcU5iTEVldHl3bzA3MkE?oc=5",
    "date": "2017-09-21T07:00:00.000Z",
    "dateFormatted": "21/09/2017",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "South Korean drugmaker slapped with FDA warning letter, import alert  Fierce Pharma",
    "company": "TBD",
    "types": [
      "warning_letter",
      "import_alert"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "f05ce8c1e08e2cd9c986bc9e308b7929",
    "title": "Orexigen Therapeutics, Inc. (Contrave) Untitled Letter 5/18/2017 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxPQ3JlRXQ1eG9BcWp1RG5iR0h1aW11blJvMkRGXzI1ZWJNZ2RCd1N0bTlwSVpCVHpISUVEWExwRWNpN013NFdIbk1MTWRxVDM0ODBHbGlQUjhMeU1YazFWdFk5d2FxbmZOYnM4NjhCOFU1dXJTVUJmODFfYzZtYXE4cUVvbVNQb3hYMTRiV2VTUUlMV1M4Mkx4WVItQzVJNndxd3B2NkY1TUY2NGZYNEFid2dfdFdMOHNJSnM5R28tdG5QUURHVkFYbTBiUmtWZllkRTBSZTZoODJtdEZZT2xzelZtQjNSVm9yeVE?oc=5",
    "date": "2017-05-23T07:00:00.000Z",
    "dateFormatted": "23/05/2017",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Orexigen Therapeutics, Inc. (Contrave) Untitled Letter 5/18/2017  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "342d410d0e0018715fc8aedf2ffd8351",
    "title": "Import ban extended as India's Pan Pharma racks up third FDA warning letter - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQS0RQc0FMZm5LYmRKa1dqV1ZPbVJINmxJUGVVX0w1cWJRbFVLcXZJOF9oclcwd3pZNFRZaWFtRGxVd1ZFeGM4azFaLVNKZzFkcmpjODJ6cnVaMGc4RGpFRlRuUlZGSDRhX2k2cFk1Z2hPNndCVjNxRzR5SEg3bVI4RTRoZklNbUxDWTMxZWx6QmpLblcxUXFnclg1Z3BkVkxtR095T2ZyblJpOGs?oc=5",
    "date": "2016-09-07T07:00:00.000Z",
    "dateFormatted": "07/09/2016",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Import ban extended as India's Pan Pharma racks up third FDA warning letter  Fierce Pharma",
    "company": "TBD",
    "types": [
      "warning_letter",
      "import_alert"
    ],
    "severity": 8,
    "priority": 3
  }
]